N. Yamamoto

N. Yamamoto, V. R. Naraparaju, Y. Koga, 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Genomic masking and recombination between serologically unrelated phages P22 and P221.

T. F. Anderson, N. Yamamoto, 1961, Virology.

Roles of beta-galactosidase of B lymphocytes and sialidase of T lymphocytes in inflammation-primed activation of macrophages.

N. Yamamoto, V. R. Naraparaju, 1994, Immunology letters.

λimmP22dis: A hybrid of coliphage λ with both immunity regions of Salmonella phage P22

P. Gemski, L. Baron, N. Yamamoto, 1978, Molecular and General Genetics MGG.

RETRACTED ARTICLE: Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor, GcMAF

N. Yamamoto, N. Yamamoto, Y. Koga, 2008, Cancer Immunology, Immunotherapy.

Structurally well‐defined macrophage activating factor derived from vitamin D3‐binding protein has a potent adjuvant activity for immunization

N. Yamamoto, V. R. Naraparaju, Venkateswara R Naraparaju, 1998, Immunology and cell biology.

Structural definition of a potent macrophage activating factor derived from vitamin D3-binding protein with adjuvant activity for antibody production.

N. Yamamoto, 1996, Molecular immunology.

Prognostic utility of serum alpha-N-acetylgalactosaminidase and immunosuppression resulted from deglycosylation of serum Gc protein in oral cancer patients.

N. Yamamoto, V. R. Naraparaju, M. Urade, 1997, Cancer research.

Participation of serum proteins in the inflammation-primed activation of macrophages

N. Yamamoto, N. P. Willett, D. D. Lindsay, 1994, Inflammation.

In vivo and in vitro activation of macrophages with a cyanine photosensitizing dye, platonin

I. Yamamoto, N. Yamamoto, S. Homma, 1993, Cancer Immunology, Immunotherapy.

Defective lymphocyte glycosidases in the macrophage activation cascade of juvenile osteopetrosis.

P. Orchard, N. Yamamoto, V. R. Naraparaju, 1996, Blood.

Pathogenic Significance of α-N-Acetylgalactosaminidase Activity Found in the Envelope Glycoprotein gp160 of Human Immunodeficiency Virus Type 1

N. Yamamoto, 2006 .

Analysis of proteins induced by the Salmonella typhimurium Phage P221, a hybrid between serologically and morphologically unrelated phages P22 and Fels 1.

N. Yamamoto, M. Droffner, 1982, The Journal of general virology.

Antitumor Effect of Vitamin D-Binding Protein-Derived Macrophage Activating Factor on Ehrlich Ascites Tumor-Bearing Mice

N. Yamamoto, V. R. Naraparaju, Y. Koga, 1999 .

Retracted: Immunotherapy of HIV‐infected patients with Gc protein‐derived macrophage activating factor (GcMAF)

N. Yamamoto, Y. Koga, Naofumi Ushijima, 2009, Journal of medical virology.

A generalized transducing salmonella phage ES18 can recombine with a serologically unrelated phage Fels 1.

N. Yamamoto, 1978, The Journal of general virology.

Deglycosylation of serum vitamin D3-binding protein by alpha-N-acetylgalactosaminidase detected in the plasma of patients with systemic lupus erythematosus.

N. Yamamoto, V. R. Naraparaju, L. Brent, 1997, Clinical immunology and immunopathology.

Pathogenic significance of alpha-N-acetylgalactosaminidase activity found in the envelope glycoprotein gp160 of human immunodeficiency virus Type 1.

N. Yamamoto, 2006, AIDS research and human retroviruses.

Vitamin D3-binding protein as a precursor for macrophage activating factor in the inflammation-primed macrophage activation cascade in rats.

N. Yamamoto, V. R. Naraparaju, 1996, Cellular immunology.

Structural modification of serum vitamin D3-binding protein and immunosuppression in AIDS patients.

N. Yamamoto, V. R. Naraparaju, S. Srinivasula, 1995, AIDS research and human retroviruses.

Inhibitory effect of vitamin D-binding protein-derived macrophage activating factor on DMBA-induced hamster cheek pouch carcinogenesis and its derived carcinoma cell line.

N. Yamamoto, H. Kishimoto, M. Urade, 2011, Oncology letters.

Macrophage-directed immunotherapy as adjuvant to photodynamic therapy of cancer.

M. Korbelik, M. Korbelik, N. Yamamoto, 1997, British Journal of Cancer.

Vitamin D‐binding protein (group‐specific component) is the sole serum protein required for macrophage activation after treatment of peritoneal cells with lysophosphatidylcholine

M. Yamamoto, N. Yamamoto, N. Yamamoto, 1993, Immunology and cell biology.

Pathogenic significance of alpha-N-acetylgalactosaminidase activity found in the hemagglutinin of influenza virus.

N. Yamamoto, M. Urade, 2005, Microbes and infection.

A defect in inducible β‐galactosidase of B lymphocytes in the osteopetrotic (mi/mi) mouse

N. Yamamoto, V. R. NARAPARAJU, 1996, Immunology.

Role of vitamin D3-binding protein in activation of mouse macrophages.

N. Yamamoto, V. R. Naraparaju, 1996, Journal of immunology.

A New Procedure for Experimental Autoimmune Uveitis with Small Uveitogenic Peptides

R. Eagle, N. Yamamoto, Masumi Ueda, 2006, Ocular immunology and inflammation.

A serum factor for macrophage activation after in vitro dodecylglycerol treatment of mouse lymphocytes

I. Millman, N. Yamamoto, N. Yamamoto, 1990, Immunology and cell biology.

Potent Tumoricidal Capacity of Macrophages Activated by Gc Protein-Derived Macrophage Activating Factor (GcMAF) and Its Therapeutic Efficacy for Prostate, Breast and Colorectal Cancers

N. Yamamoto, M. Urade, Masumi Ueda, 2005 .

Activation of macrophages by ether analogues of lysophospholipids

N. Yamamoto, B. Ngwenya, T. Sery, 2004, Cancer Immunology, Immunotherapy.

TUMORICIDAL CAPACITIES OF MACROPHAGES PHOTODYNAMICALLY ACTIVATED WITH HEMATOPORPHYRIN DERIVATIVE

N. Yamamoto, J K Hoober, N Yamamoto, 1992, Photochemistry and photobiology.

A defect in beta-galactosidase of B lymphocytes in the osteopetrotic (op/op) mouse.

N. Yamamoto, V. R. Naraparaju, 1996, Immunology Letters.

Contribution of Lysophosphatidylcholine-Treated Nonadherent Cells to Mechanism of Macrophage Activation

N. Yamamoto, N. Yamamoto, B. Ngwenya, 1990, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Effects of inflammation products on immune systems

N. Yamamoto, N. Yamamoto, B. Ngwenya, 1986, Cancer Immunology, Immunotherapy.

Deglycosylation of Serum Vitamin D 3-Biniding Protein Leads to Immunosuppression in Can

N. Yamamoto, 2017 .

A defect in β-galactosidase of B lymphocytes in the osteopetrotic (opop) mouse

N. Yamamoto, V. R. Naraparaju, 1996 .

Activation ofMacrophages by TwoSerumFactors, Vitamin D3-Binding Protein andAlbumin

R. Kumashiro, N. Yamamoto, Masashi Yamamoto, 1993 .

Genetic studies of hybrids between coliphage λ and Salmonella phage P22: Genetic analysis of the P22-λ hybrid class

P. Gemski, L. Baron, N. Yamamoto, 1977, Molecular and General Genetics MGG.

Properties of cell-free extracts fromBacillus subtilis and its thermophilic mutant

N. Yamamoto, S. Marvin Friedman, 1990, Current Microbiology.